Skip to main content

Humana Inc(HUM-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Why Humana Stock Withered on Wednesday

Motley Fool - Wed Apr 24, 6:15PM CDT

Humana(NYSE: HUM) stock has not been a favorite of investors this year, and the health insurer's first-quarter earnings report published Wednesday morning did nothing to change that. Following its release the company's stock traded down, to the point where it closed Hump Day down by almost 4% in price. Meanwhile, the bellwether S&P 500 index did relatively better, trading more or less sideways on the day.

Revenue and adjusted net income went in opposite directions

For the quarter, Humana's revenue according to non-GAAP (adjusted) standards totaled $29.6 billion, which was a healthy 14% higher on a year-over-year basis. Contrasting this was adjusted net income; this fell by a fairly steep 23% to just under $1.2 billion ($7.31 per share).

Both headline figures topped the consensus analyst estimates. These called for $28.5 billion in revenue and adjusted net income of $6.12 per share.

Humana, a top provider of Medicare Advantage (MA) plans, said that its better-than-expected numbers were mainly due to administrative expenses that came in lower than anticipated. Yet operating in the MA space isn't necessarily advantageous these days. That's because earlier this month, the U.S. Centers for Medicare and Medicaid Services (CMS) set a payment rate increase for the program that was notably lower than many expected.

Profitability guidance disappointed the market

In its earnings release and in prepared remarks about the quarter, Humana management reaffirmed its adjusted, per-share net income guidance of roughly $16 per share for full-year 2024. That, unfortunately, is under the $16.36 collective analyst estimate. The company did not provide a forecast for annual revenue.

Should you invest $1,000 in Humana right now?

Before you buy stock in Humana, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy nowโ€ฆ and Humana wasnโ€™t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.

See the 10 stocks

*Stock Advisor returns as of April 22, 2024

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Paid Post: Content produced by Motley Fool. The Globe and Mail was not involved, and material was not reviewed prior to publication.